Cell Microsystems Introduces Lab Services for Cell Line and Organoid Development
Cell Microsystems has expanded its contract research lab services to include cell line and custom organoid development, utilizing its proprietary CellRaft Technology. This technology facilitates the generation of viable cell colonies from difficult cell types, addressing a common challenge in current cell culture methodologies.
The CellRaft Technology employs a microwell array system that allows for the isolation, culture, and monitoring of individual cells. This system supports the development of organoids, which are three-dimensional cell cultures used to model organ function and disease. The precision of this technology ensures the integrity and quality of cell lines and organoids, providing researchers with reliable and reproducible results.
Key Features of CellRaft Technology:
- Isolation and Culture: Allows for the precise handling of individual cells.
- Monitoring: Ensures integrity and reproducibility of results.
- Organoid Development: Supports the creation of complex, 3D cell structures for research.
Cell Microsystems' expanded services are designed to complement its existing offerings, providing comprehensive solutions for cellular research. These new services include:
- Cell Analysis Under Shear Flow Conditions: Replicates physiological environments to study cell behavior.
- Automated Patch Clamp Assays for Ion Channels: Facilitates high-throughput analysis essential for drug discovery.
The introduction of these new lab services follows the success of Cell Microsystems' Clone Challenge Grant Giveaway. The initiative demonstrated the technology's capability in assisting researchers who had difficulties developing cell lines using traditional methods. The expansion aims to make these advanced capabilities accessible to a broader range of scientists.
Gary Pace, CEO of Cell Microsystems, emphasized that the CellRaft Technology accelerates research and discovery, while Jessica Hartman, Senior Director of Product Applications and Lab Services, highlighted the Clone Challenge's demonstration of the technology's practical benefits, now made available to more researchers through the expanded services.
Cell Microsystems' portfolio includes the CellRaft AIR System for monoclonal colony growth, the BioFlux Shear Flow Systems for in vivo condition replication, and the CERO 3D Cell Culture & Bioreactor for long-term organoid growth. These tools and services are designed to support various stages of the research pipeline, from initial cell line development to advanced functional assays.
Topics: Tools & Methods
